Skip to main content
Premium Trial:

Request an Annual Quote

Chinese Dx Firm iGenomics to Purchase 32 Ion Proton Sequencers

NEW YORK (GenomeWeb News) – Privately held Chinese diagnostics services firm iGenomics has purchased 17 of Life Technologies' Ion Proton next-generation sequencing systems and has agreed to add 15 more machines by the end of the year, Life Tech said today.

Guangzhou, China-based iGenomics will initially use the sequencers for research in aneuploidy screening, but plans to expand into other applications.

"We see a huge growth opportunity in sequencing and believe that Ion Torrent provides the ideal technology to help us quickly expand and compete in this market today and in the future," iGenomics CEO Shengyu Huang said in a statement.

Over the last six months, iGenomics has performed more than 200 runs on the Proton with a protocol that delivers over 80 million reads per run on the PI chip and up to six runs in one day.

The company also signed a licensing and supply agreement with Life Tech. Financial details of the deal were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.